Nebivolol Other names: Nebivolol hydrochloride

Chemical formula: C₂₂H₂₅F₂NO₄  Molecular mass: 405.435 g/mol  PubChem compound: 71301

Therapeutic indications

Nebivolol is indicated for:

Hypertension

Population group: only adults (18 - 65 years old)

Hypertension

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Chronic heart failure (CHF)

Population group: only adults (18 years old or older)

Chronic heart failure

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Hypertension

Population group: only elderly (65 years old or older)

Hypertension

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Nebivolol is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Liver insufficiency

Hepatic insufficiency

Acute heart failure

Acute heart failure

Cardiogenic shock

Cardiogenic shock

Sick sinus syndrome

Sick sinus syndrome

Sinoatrial block

Sinoatrial block

Second degree atrioventricular block (without a pacemaker)

Second degree atrioventricular block

Third degree heart block (without a pacemaker)

Complete atrioventricular block

Bronchospasm

Bronchospasm

Bronchial asthma

Airway hyperreactivity

Pheochromocytoma

Phaeochromocytoma

Metabolic acidosis

Metabolic acidosis

Bradycardia (heart rate <60 bpm prior to start therapy)

Bradycardia

Hypotension (systolic blood pressure <90 mmHg)

Hypotension

Severe peripheral arterial circulatory disturbances

Peripheral arterial occlusive disease

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2020: BYSTOLIC Tablet
Summary of Product Characteristics (SPC) 2018: NEBILET Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈